$26.38
+0.51 (+1.97%)
Performance
1D
-0.11%
1W
+1.97%
1M
+7.24%
3M
-3.30%
6M
-16.91%
1Y
+18.78%
YTD
-2.80%
Open$26.03
Previous Close$25.87
Day High$26.78
Day Low$25.84
52W High$38.26
52W Low$20.23
Volume—
Avg Volume2.15M
Market Cap2.73B
P/E Ratio—
EPS$-0.81
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$25.58
Above
SMA 200
$28.00
Below
RSI (14)
57.8
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+135.3% upside
Current
$26.38
$26.38
Target
$62.07
$62.07
$37.88
$62.07 avg
$80.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 146.06M | 110.75M | 476.44M |
| Net Income | -83,612,088 | -57,060,114 | -46,993,180 |
| Profit Margin | -57.2% | -54.4% | -9.9% |
| EBITDA | -377,743,040 | -272,107,892 | -41,088,618 |
| Free Cash Flow | — | — | -33,034,013 |
| Rev Growth | +31.9% | +31.9% | -6.6% |
| Debt/Equity | — | — | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |